Sources | Names Used |
---|---|
CTRPv2 | selumetinib:PLX-4032 (8:1 mol/mol) |
PharmacoGx | selumetinib:PLX-4032 (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAND2 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
mRNA | RAB33B | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
mRNA | ZNF250 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
mRNA | MYBL2 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-08 |
mRNA | TLDC2 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
mRNA | JADE3 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
mRNA | ARL3 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-08 |
mRNA | YEATS2 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
mRNA | PRR3 | CTRPv2 | pan-cancer | AAC | -0.23 | 3e-08 |
mRNA | KIAA0930 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |